These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4054169)

  • 1. Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.
    Vardi P; Benderly A; Etzioni A; Levy J; Hochberg Z
    Eur J Pediatr; 1985 Sep; 144(3):280-2. PubMed ID: 4054169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 alpha-hydroxyvitamin D3 treatment of therapy-resistant symptomatic hypocalcemia in a hypoparathyroid patient with intestinal malabsorption.
    Hylander E; Madsen S
    Acta Med Scand; 1979; 205(7):603-5. PubMed ID: 474189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the 5,6-cis and 5,6-trans isomers of 25-hydroxyvitamin D3 in chronic hypoparathyroidism.
    Offermann G; Kraft D
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):784-93. PubMed ID: 579038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of neonatal hypocalcaemia to 1 alpha-hydroxyvitamin D3.
    Barak Y; Milbauer B; Weisman Y; Edelstein S; Spirer Z
    Arch Dis Child; 1979 Aug; 54(8):642-3. PubMed ID: 507920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism.
    Oikonomou D; Laina A; Xydaki A; Christopoulos C
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoparathyroidism during pregnancy: treatment with calcitriol.
    Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
    Jorgensen H; Vogt JH
    Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypoparathyroidism with 1 alpha-hydroxyvitamin D3].
    Meng XW; Xing XP; Zhou XY
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):350-2, 383. PubMed ID: 2269035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-Induced Hypocalcemia in a Patient with Established Hypoparathyroidism.
    Onyema MC; Kearney J; Dimitriadis GK
    Am J Med; 2021 May; 134(5):e321-e322. PubMed ID: 33316255
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on intestine and bone in glucocorticoid-treated patients.
    Lund B; Andersen RB; Friis T; Hjorth L; Jørgensen FS; Norman AW; Sørensen OH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():177s-181s. PubMed ID: 606415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoparathyroidism and liver disease--evidence for a vitamin D hydroxylation defect. A case report.
    Gustafsson J; Holmberg I; Hardell LI; Foucard T
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):211-4. PubMed ID: 6546465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presumptive Glucocorticoid-Induced Refractory Hypocalcemia in a Dog with Idiopathic Immune-Mediated Hypoparathyroidism, Thrombocytopenia, and Hemolytic Anemia.
    Jaffey J; DeClue A; Cannon A; Tocci L; Hyland J
    J Am Anim Hosp Assoc; 2019; 55(1):e55104. PubMed ID: 30427709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
    Hill LF; Davies M; Taylor CM; Standbury SW
    Clin Endocrinol (Oxf); 1976; 5 Suppl():167S-173S. PubMed ID: 1052776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
    Chan JC; Oldham SB; Holick MF; DeLuca HF
    JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hypoparathyroidism. Trials of 1 alpha-hydroxycholecalciferol (1 alpha-(OH)D3)].
    Jorgensen H; Vogt JH
    Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1069-72. PubMed ID: 905981
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin D metabolism in hypoparathyroidism.
    Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
    J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium imbalance in hypoparathyroidism.
    Gupta MM
    J Assoc Physicians India; 1991 Aug; 39(8):616-8. PubMed ID: 1669288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.